Clinical Significance of Anti‐Ata
- 1 August 1995
- journal article
- case report
- Published by Wiley in Vox Sanguinis
- Vol. 69 (2), 135-137
- https://doi.org/10.1111/j.1423-0410.1995.tb01684.x
Abstract
Ata is a high-frequency red blood cell (RBC) antigen. Anti-At(a) has been reported in rare At(a-) black subjects. We report two cases of anti-At(a). A clinically significant anti-At(a) was found in a 26-year-old black woman with systemic lupus erythematosus. The patient had a transfusion reaction with chills and nausea during a RBC survival study, and 95% of the radiolabeled At(a+) RBCs were destroyed within 3 h. A concurrently performed monocyte monolayer assay was strongly reactive. Anti-At(a) thus can cause rapid hemolysis of transfused RBCs, but At(a-) donor units are extremely scarce in rare donor registries. A second patient at our hospital had anti-At(a) which did not affect her newborn. She also had autoimmune disease, insulin-dependent diabetes mellitus.Keywords
This publication has 12 references indexed in Scilit:
- At(a−) phenotype: description of a family and reduced survival of At(a+) red cells in a proposita with anti‐AtaTransfusion, 1995
- Long‐term follow‐up testing of red cell alloantibodiesTransfusion, 1994
- Blood Group Terminology 19901Vox Sanguinis, 1990
- Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assayTransfusion, 1987
- Anti‐Ata causing mild hemolytic disease of the newbornTransfusion, 1987
- Ata (August) and El (Eldr) Are SynonymousVox Sanguinis, 1983
- Six Additional Examples of Anti‐AtaTransfusion, 1973
- Recommended Methods for Radioisotope Red‐Cell Survival Studies* A REPORT BY THE ICSH PANEL ON DIAGNOSTIC APPLICATIONS OF RADIOISOTOPES IN HAEMATOLOGYBritish Journal of Haematology, 1971
- Three New Antibodies to High‐incidence Antigenic Determinants (Anti‐El, Anti‐Dp, and Anti‐So)Transfusion, 1970
- A Very Frequent Red Cell Antigen, AtaVox Sanguinis, 1967